Lv31
302 积分 2024-04-17 加入
Complement activation and effector pathways in membranous nephropathy
2小时前
已完结
IL-6 receptor blockade impedes proinflammatory atypical Treg subset associated with immune checkpoint inhibitor-induced inflammatory arthritis
17天前
已完结
Single cell suppression profiling of human regulatory T cells
17天前
已完结
PPAR-γ signaling in nonalcoholic fatty liver disease: Pathogenesis and therapeutic targets
2个月前
已完结
Advances in pathogenesis and therapeutic strategies for osteoporosis
2个月前
已完结
USP1 inhibition: A journey from target discovery to clinical translation
2个月前
已完结
Allosteric small-molecule kinase inhibitors
2个月前
已完结
Metal-dependent Ser/Thr protein phosphatase PPM family: Evolution, structures, diseases and inhibitors
2个月前
已完结
Atrasentan in Patients with IgA Nephropathy
2个月前
已完结
A Phase 2 Trial of Sibeprenlimab in Patients with IgA Nephropathy
2个月前
已完结
皖公网安备34019202002308
